Compugen (Israel) Today
| CGEN Stock | ILA 516.60 5.00 0.96% |
Performance0 of 100
| Odds Of DistressLess than 13
|
Compugen is trading at 516.60 as of the 27th of November 2024, a 0.96% down since the beginning of the trading day. The stock's open price was 521.6. Compugen has less than a 13 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Compugen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. The company has 86.62 M outstanding shares. More on Compugen
Moving together with Compugen Stock
Moving against Compugen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Compugen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Compugen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Compugen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Anat CohenDayag |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Compugen (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 73 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 251.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compugen's market, we take the total number of its shares issued and multiply it by Compugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Compugen operates under Healthcare sector and is part of Biotechnology industry. The entity has 86.62 M outstanding shares.
Compugen has accumulated about 110.41 M in cash with (22.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.
Check Compugen Probability Of Bankruptcy
Ownership AllocationCompugen holds a total of 86.62 Million outstanding shares. Compugen shows 5.5 percent of its outstanding shares held by insiders and 27.56 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Compugen Ownership Details
Compugen Risk Profiles
Although Compugen's alpha and beta are two of the key measurements used to evaluate Compugen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.0 | |||
| Standard Deviation | 3.99 | |||
| Variance | 15.96 | |||
| Risk Adjusted Performance | (0.04) |
Compugen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Compugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Compugen Corporate Directors
| Michal Preminger | Director | Profile | |
| Arie Ovadia | Independent External Director | Profile | |
| Eran Perry | Director | Profile | |
| Sanford Zweifach | Director | Profile |
Additional Information and Resources on Investing in Compugen Stock
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Compugen Stock refer to our How to Trade Compugen Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.